Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2020 Financial Results
Day-90 Analysis of FX-322 Phase 2a Study for Acquired Sensorineural Hearing Loss (SNHL) Planned for Late Q1 2021; End of...
Staff
Grapefruit USA, Inc. Reports 677% Revenue Growth Year-Over-Year; 48% Revenue Growth QuarterOver-Quarter, Margins Expand; CEO Recaps Overall Incredible Quarter
LOS ANGELES, CA and DESERT HOT SPRINGS, CA / ACCESSWIRE / November 16, 2020 / Grapefruit USA, Inc., ("GPFT", "Grapefruit"...
Study Investigates Effects of Patient Blood Management Program with Masimo SpHb®, Noninvasive, Continuous Hemoglobin Monitoring, on Postoperative Cancer Patients
Patient Blood Management with Masimo SpHb Increased Transfusion Appropriateness and Decreased RBC Units Transfused per Patient NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ:...
IHF LLC Adds New Terpenes to Their Online Store
As the Colorado operations continue to expand its scope and product lines, terpenes are among the areas where new products...
Adverum Biotechnologies Announces Positive Interim Data from Cohorts 1-4 from OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD
-- Maintained efficacy and greatly reduced anti-VEGF treatment burden after a single IVT injection of ADVM-022 -- -- Robust preliminary aqueous...
RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2020 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused...
Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (“Tarsus” NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose...
VIVUS Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date
CAMPBELL, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- On November 10, 2020, VIVUS, Inc. (the “Company”), a biopharmaceutical company, filed the...
Diabetes Freedom Reviews – Diabetes Reversal Solution Diabetes Freedom By James Freeman Analyzed
Diabetes Freedom reviews by James Freeman. Diabetes reversal type 2 diabetes freedom program truth and facts. The eBook any good?...
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil
HAUPPAUGE, N.Y., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious...
BeyondSpring to Present Corporate Overview at Jefferies London Healthcare Conference
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company...
Pacific Health Care Organization, Inc. Reports Third Quarter 2020 Results
Newport Beach, CA, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed...
FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease
FDA issues Complete Response Letter for sutimlimab, an investigational treatment for hemolysis in adults with cold agglutinin disease * ...
Atrion Corporation Declares Quarterly Cash Dividend
ALLEN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced that its Board of Directors declared...
SmileDirectClub to Participate in Upcoming Investor Conferences
NASHVILLE, Tenn., Nov. 13, 2020 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the oral care company with the first medtech...
SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2020 Financial Results
- Received IMPD Approval to Commence Enrollment in France for Pivotal Phase 3 Study of Galinpepimut-S in Acute Myeloid Leukemia...
Zosano Pharma Reports Third Quarter 2020 Financial Results
FREMONT, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for...
Adamas Announces New Employment Inducement Grant
EMERYVILLE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of...
Phathom Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
FLORHAM PARK, N.J., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on...
Major shareholder notification – Société Générale S.A.
GN Store Nord A/S hereby announces that on November 13, 2020 it received a notification from Société Générale S.A. stating...